Multicenter Study of Fulminant Type 1 Diabetes in China

RecruitingOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

May 20, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Diabetes Mellitus, Type 1
Interventions
GENETIC

HLA

Distinguish based on clinical features

Trial Locations (10)

4100011

RECRUITING

Changsha Central Hospital, Changsha

RECRUITING

The Second Xiangya Hospital of Central South University, Changsha

Unknown

RECRUITING

Quanzhou First People's Hospital, Quanzhou

RECRUITING

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou

RECRUITING

The First Affiliated Hospital of Guangxi Medical University, Nanning

RECRUITING

Guizhou Provincial People's Hospital, Zunyi

RECRUITING

Hainan Provincial People's Hospital, Haikou

RECRUITING

Yancheng Third People's Hospital, Yancheng

RECRUITING

The First Affiliated Hospital of Nanchang University, Nanchang

RECRUITING

Yunnan Provincial People's Hospital, Kunming

All Listed Sponsors
lead

Second Xiangya Hospital of Central South University

OTHER